MEK-inhibitors/arsenic trioxide combination therapy as a novel treatment option for tyrosine kinase inhibitors-resistant ph+-leukemia
Mazzera L, Abeltino M, Lombardi° G, Cantoni AM, Jottini S, Corradi A, Ricca° M, Arienti° D, Peli A, Perris R, Bonati A, Lunghi P
Congress of the Italian Society of Experimental Hematology (16th : Napoli, Italy : October 15-17, 2020)
Haematologica . – Vol. 105 s2 (2020) . – p s68-s69
ultimo accesso 10/05/2021 https://doi.org/10.3324/haematol.2020.s2
Nr. Estr. 8632